 |
1. Savolainen J. et al., M.Candida albicans and atopic dermatitis. Clin Exp Allergy ;23:332-9, 1993
2. Patrizi A. et al, Clinical evaluation of the efficacy and tolerability of the “NoAll Bimbi Pasta Trattante”barrier cream in napkin dermatitis. Minerva Pediatr;59(1):23-8, 2007]
3. Johansson C. et al, Atopy patch test reaction to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br J dermatol;148(3):479-88, 2003
4. 浅古佳子ら、Candida albicans, Malassezia furfurの精製抗原に対するアトピー性皮膚炎患者の反応性に対する検討. アレルギー;51(8):615-21, 2002
5. Sugita T. et al, アトピー性皮膚炎患者皮膚に定着する担子菌系酵母Cryptococcus diffluens及びC.liquefaciens. Microbiology and Lmmunology;47(12):945-50, 2003
6. Kato Hiroshi et al, 酵素免疫測定法を用いたアトピー性皮膚炎患者の8種の血清中マラセジア菌に対する特異的IgE抗体の検出と定量化. Microbiology and Lmmunology;50(11):851-56, 2006
7. Sugita T. et al, アトピー性皮膚炎および健常人皮膚に定着するMalassezia retrictaの遺伝子多型. Microbiology and Lmmunology;48(10):755-59, 2004
8. 小林照子ら、アトピー性皮膚炎における真菌アレルギーと抗真菌療法の効果についての検討 即時型反応、遅延型反応を含めて. アレルギー;55(2):126-33, 2006
9. Mayser P. et al, Treatment of head and neck dermatitis with ciclopiroxolamine cream?results of a double-blind, placebo-controlled study. Skin Pharmacol Physiol ;19:153-158, 2006
10. Wong AW. et al, Is topical antimycotic treatment useful as ajuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control. Int J Dermatol;47(2):187-91, 2008
11. Takechi M. Minimum effective dosage in the treatment of chronic atopic dermatitis with itraconazole. J Int Med Res.;33(3):273-83, 2005
12. Svejgaard EL. et al, Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol;18(4):445-9, 2004
13. 田嶋 麿美、Malasseziaと脂漏性皮膚炎・アトピー性皮膚炎. 真菌誌;46:163-7, 2005
|
|
